Cephalosporins: a focus on side chains and β-lactam cross-reactivity SB Chaudhry, MP Veve, JL Wagner Pharmacy 7 (3), 103, 2019 | 128 | 2019 |
Lefamulin: review of a promising novel pleuromutilin antibiotic MP Veve, JL Wagner Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 38 (9 …, 2018 | 102 | 2018 |
Evaluation of clinical outcomes in patients with bloodstream infections due to Gram-negative bacteria according to carbapenem MIC stratification JS Esterly, J Wagner, MM McLaughlin, MJ Postelnick, C Qi, MH Scheetz Antimicrobial agents and chemotherapy 56 (9), 4885-4890, 2012 | 98 | 2012 |
Comparison of fosfomycin to ertapenem for outpatient or step-down therapy of extended-spectrum β-lactamase urinary tract infections MP Veve, JL Wagner, RM Kenney, JL Grunwald, SL Davis International journal of antimicrobial agents 48 (1), 56-60, 2016 | 66 | 2016 |
Elbasvir/grazoprevir: a review of the latest agent in the fight against hepatitis C AM Bell, JL Wagner, KE Barber, KR Stover International journal of hepatology 2016, 2016 | 54 | 2016 |
Intravenous vancomycin dosing in the elderly: a focus on clinical issues and practical application KE Barber, AM Bell, KR Stover, JL Wagner Drugs & aging 33, 845-854, 2016 | 36 | 2016 |
Omadacycline enters the ring: a new antimicrobial contender KE Barber, AM Bell, MJB Wingler, JL Wagner, KR Stover Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 38 (12 …, 2018 | 25 | 2018 |
Diabetic foot infections: A microbiologic review BK Hawkins, M Barnard, KE Barber, KR Stover, DA Cretella, MJB Wingler, ... The Foot 51, 101877, 2022 | 24 | 2022 |
Impact of an antifungal stewardship intervention on optimization of candidemia management H Rac, JL Wagner, ST King, KE Barber, KR Stover Therapeutic advances in infectious disease 5 (1), 3-10, 2018 | 18 | 2018 |
Trends in and predictors of carbapenem consumption across North American hospitals: results from a multicenter survey by the MAD-ID research network NJ Rhodes, JL Wagner, SL Davis, JA Bosso, DA Goff, MJ Rybak, ... Antimicrobial agents and chemotherapy 63 (7), 10.1128/aac. 00327-19, 2019 | 17 | 2019 |
Surgical prophylaxis with gram‐negative activity for reduction of surgical site infections after microvascular reconstruction for head and neck cancer JL Wagner, RM Kenney, JA Vazquez, TA Ghanem, SL Davis Head & neck 38 (10), 1449-1454, 2016 | 17 | 2016 |
Epidemiology and outcomes associated with anemia during long-term support with continuous-flow left ventricular assist devices DL Jennings, JL Wagner, L To, CW Nemerovski, JS Kalus, JA Morgan, ... Journal of cardiac failure 20 (6), 387-391, 2014 | 17 | 2014 |
Real-world, multicentre evaluation of the incidence and risk factors for non-susceptible Stenotrophomonas maltophilia isolates BM Jones, JL Wagner, DB Chastain, PB Bookstaver, K Stover, J Lin, ... Journal of Global Antimicrobial Resistance 28, 282-287, 2022 | 16 | 2022 |
Impact of Obesity in Patients with Candida Bloodstream Infections: A Retrospective Cohort Study KE Barber, JL Wagner, JM Miller, EA Lewis, KR Stover Infectious diseases and therapy 9, 175-183, 2020 | 16 | 2020 |
Growing resistance in Stenotrophomonas maltophilia? HH Matson, BM Jones, JL Wagner, MA Motes, CM Bland American Journal of Health-System Pharmacy 76 (24), 2004-2005, 2019 | 15 | 2019 |
Allergic reactions and cross-reactivity potential with beta-lactamase inhibitors KR Stover, KE Barber, JL Wagner Pharmacy 7 (3), 77, 2019 | 15 | 2019 |
Impact of obesity on acyclovir-induced nephrotoxicity KE Barber, JL Wagner, KR Stover Open forum infectious diseases 6 (4), ofz121, 2019 | 15 | 2019 |
Financial analysis of dalbavancin for acute bacterial skin and skin structure infections for self-pay patients AG Pizzuti, EY Murray, JL Wagner, DA Gaul, CM Bland, BM Jones Infectious Diseases and Therapy 9, 1043-1053, 2020 | 12 | 2020 |
Abnormal QTc syndrome in HIV-infected patients: a systematic review of prevalence and risk factors DB Chastain, MP Veve, JL Wagner Antiviral therapy 24 (6), 459-465, 2019 | 12 | 2019 |
Best practices in syllabus design JL Wagner, KJ Smith, C Johnson, ML Hilaire, MS Medina American Journal of Pharmaceutical Education 87 (3), ajpe8995, 2023 | 10 | 2023 |